Cardiovascular risk and inhibition of cyclooxygenase: traditional nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors. Italian Journal of Medicine, v. 1, n. 1, p. 37–54, 3 May2013.